StockData

Nutra Pharma Corp (NPHC) stock

NPHCOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 1/30
$0.00+0.00 (0.00%)

Close on Oct 19, 2026Market cap $806.69KP/E –Yield –

Nutra Pharma price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nutra Pharma's price to sales ratio was 4.5× on Oct 19, 2026, against 2.3× a year earlier. Over the last 5 years it ranged from 0.0× to 277.5×, with a median of 3.8×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20264.5×+2.2
2025Dec 31, 20252.3×−1.1
2024Dec 31, 20243.4×+0.4
2023Dec 29, 20233.0×−5.2
2022Dec 30, 20228.2×−160.0
2021Dec 31, 2021168.2×−1.8
2020Dec 31, 2020170.0×+148.8
2019Dec 31, 201921.2×+12.5
2018Dec 31, 20188.7×+1.5
2017Dec 29, 20177.2×+3.1
2016Dec 30, 20164.1×−1.8
2015Dec 31, 20156.0×−6.7
2014Dec 31, 201412.7×−16.2
2013Dec 31, 201328.8×+20.0
2012Jan 31, 20128.8×−2.9
2011Dec 30, 201111.7×–

More Nutra Pharma figures

See a number that looks wrong?